Product Information
LEVONOR-ETH ESTRAD 0.15-0.03 is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.1125 per EA under NDC 00378655053. Its NADAC has been published 657 times since Nov 28, 2013.
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378655053
Classification
Generic
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA091663On Market Since
8/16/2013
Price Statistics
The NADAC for LEVONOR-ETH ESTRAD 0.15-0.03 has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 82.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1125 per EA |
|---|---|
| All-time high | $0.6294 (Dec 11, 2013) |
| All-time low | $0.0800 (Nov 20, 2024) |
| 52-week high | $0.1210 |
| 52-week low | $0.1101 |
| Median price | $0.2350 |
| Average price | $0.2867 |
| Largest weekly change | +72.0% (Aug 21, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LEVONOR-ETH ESTRAD 0.15-0.03?
The current National Average Drug Acquisition Cost (NADAC) for LEVONOR-ETH ESTRAD 0.15-0.03, manufactured by Mylan Pharmaceuticals Inc., is $0.1125 per EA (NDC 00378655053), effective Jun 24, 2026.
How has the price of LEVONOR-ETH ESTRAD 0.15-0.03 changed over time?
Over the history we have for it, the NADAC for LEVONOR-ETH ESTRAD 0.15-0.03 has declined 82.1%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LEVONOR-ETH ESTRAD 0.15-0.03?
Since Nov 28, 2013, the NADAC for LEVONOR-ETH ESTRAD 0.15-0.03 has ranged from a low of $0.0800 (Nov 20, 2024) to a high of $0.6294 (Dec 11, 2013), with a median of $0.2350 per EA.
Are there cheaper alternatives to LEVONOR-ETH ESTRAD 0.15-0.03?
6 NADAC-published products share the same active ingredient, strength, and dosage form as LEVONOR-ETH ESTRAD 0.15-0.03, but none are currently priced below it.
Who manufactures LEVONOR-ETH ESTRAD 0.15-0.03?
LEVONOR-ETH ESTRAD 0.15-0.03 (NDC 00378655053) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification